Journal of Cancer Therapy
Vol.4 No.8(2013), Paper ID 38673, 9
pages
DOI:10.4236/jct.2013.48164
Is the CD4/CD8 Ratio an Effective Indicator for Clinical Estimation of Adoptive Immunotherapy for Cancer Treatment?
Goki Shindo, Takayoshi Endo, Masamitsu Onda, Shigenori Goto, Yoju Miyamoto, Toru Kaneko
Cardiothoracic Department, Meditopia Numazu Clinic, Numazu, Japan
Cardiothoracic Department, Meditopia Numazu Clinic, Numazu, Japan
Cardiothoracic Department, Meditopia Numazu Clinic, Numazu, Japan
Department of Immunotherapy, Seta Clinic Tokyo, Tokyo, Japan
Department of Immunotherapy, Seta Clinic Shin-Yokohama, Yokohama, Japan
Department of Immunotherapy, Seta Clinic Shin-Yokohama, Yokohama, Japan
Copyright © 2013 Goki Shindo, Takayoshi Endo, Masamitsu Onda, Shigenori Goto, Yoju Miyamoto, Toru Kaneko et al. This is
an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any
medium, provided the original work is properly cited.
How to Cite this Article
G. Shindo, T. Endo, M. Onda, S. Goto, Y. Miyamoto and T. Kaneko, "Is the CD4/CD8 Ratio an Effective Indicator for Clinical Estimation of Adoptive Immunotherapy for Cancer Treatment?,"
Journal of Cancer Therapy, Vol. 4 No. 8, 2013, pp. 1382-1390. doi:
10.4236/jct.2013.48164.